Corvus Pharmaceuticals, Inc. (CRVS) Insider Trading

Name: Corvus Pharmaceuticals, Inc. (CRVS) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Jun 15, 2026): Moore David Scott (Director): Purchase of 21,700 shares, $250.2K.

Get alerted when insiders trade CRVS

Email address

Loading company data...

Beta

Loading company details...

Beta